ロード中...
Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma
We have previously conducted a phase I trial to test the efficacy of a glypican-3 (GPC3) peptide vaccine in patients with advanced hepatocellular carcinoma (HCC); however, its immunological mechanism of action remains unclear. Here, we report a pilot study conducted to evaluate the immunological mec...
保存先:
| 出版年: | Oncoimmunology |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5665076/ https://ncbi.nlm.nih.gov/pubmed/29123959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1346764 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|